International Biotechnology (LON:IBT) Shares Cross Above 200-Day Moving Average of $657.05

International Biotechnology (LON:IBTGet Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 657.05 ($8.59) and traded as high as GBX 687.95 ($9.00). International Biotechnology shares last traded at GBX 678 ($8.87), with a volume of 95,411 shares trading hands.

International Biotechnology Stock Up 0.6 %

The company has a current ratio of 0.46, a quick ratio of 0.32 and a debt-to-equity ratio of 9.66. The stock has a market capitalization of £252.07 million, a P/E ratio of 1,420.83 and a beta of 0.21. The stock’s 50 day simple moving average is GBX 681.83 and its 200 day simple moving average is GBX 657.23.

International Biotechnology Increases Dividend

The firm also recently declared a dividend, which was paid on Friday, August 23rd. Stockholders of record on Thursday, July 25th were given a GBX 14.50 ($0.19) dividend. This is an increase from International Biotechnology’s previous dividend of $13.90. This represents a dividend yield of 2.28%. The ex-dividend date was Thursday, July 25th. International Biotechnology’s dividend payout ratio (DPR) is presently 6,041.67%.

Insider Transactions at International Biotechnology

In other International Biotechnology news, insider Gillian Elcock purchased 1,407 shares of International Biotechnology stock in a transaction dated Wednesday, July 24th. The shares were bought at an average cost of GBX 709 ($9.27) per share, for a total transaction of £9,975.63 ($13,045.15). Insiders own 4.18% of the company’s stock.

About International Biotechnology

(Get Free Report)

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.

Further Reading

Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.